Market Overview:
The global 3D perfusion bioreactor system market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for 3D cell culture systems, rising R&D expenditure by biopharmaceutical companies, and technological advancements in 3D perfusion bioreactors. Based on type, the global 3D perfusion bioreactor system market can be segmented into components and devices. The components segment is further sub-segmented into media and hardware. The devices segment is further sub-segmented into single use and traditional systems. Based on application, the global 3D perfusion bioreactor system market can be divided into three segments:biopharmaceutical companies, biotech companies, and others (academic institutions & research laboratories). Geographically, the global 3D perfusion bioreactor system market can be classified into five regions: North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
A 3D perfusion bioreactor system is a biotechnology device used to cultivate cells or tissues in three dimensions. The system circulates a nutrient-rich solution through the tissue, providing it with all the oxygen and nutrients it needs to grow. This allows for more accurate study of how cells and tissues behave in three dimensions, which is important for drug development and other biomedical research.
Components:
Components are the internal parts of a system that perform specific functions. In 3D perfusion bioreactor (3DPB), components such as pumps, valves, heat exchangers, and reactors are used to carry out the desired process. The growth factor in 3DPB includes factors such as increasing demand for wastewater treatment & purification from manufacturing industries along with growing environmental concerns over industrial sludge disposal &water pollution which has led to increased use of 3D PB systems worldwide.
Device:
The device is used in 3D perfusion bioreactor system which helps to deliver the blood components with high efficiency. It also provides a controlled flow of blood components through microchannels and eliminates the need for manual mixing. The major advantages include reduced operating costs, increased productivity, improved quality and safety along with easy maintenance are driving the growth of this market globally. Moreover, increasing awareness about these devices among healthcare professionals is expected to boost demand over the forecast period.
Application Insights:
The others segment held the largest market share in terms of revenue in 2017. This application segment includes research institutes and educational institutions. The demand for perfusion bioreactor systems is increasing due to their ability to mimic physiological conditions that are required for various types of cell/tissue culture, drug screening and toxicology testing. Furthermore, these devices help reduce costs associated with toxicity testing as well as provide a controlled environment for such tests which aids in reducing experimental variability thereby enhancing the overall efficiency of the process (Kumar et al., 2016).
Rising usage of 3D printed models by pharmaceutical companies during preclinical trials has led to an increased demand for 3D printing materials which is expected to positively impact market growth over the forecast period (Garcia-Perez et al., 2017).
Regional Analysis:
North America dominated the global 3D perfusion bioreactor system market in 2017. This can be attributed to the presence of a large number of players operating in this region, which has led to an increase in awareness regarding novel technologies and their incorporation into practice. Moreover, increasing R&D activities for drug discovery and development are also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as rising healthcare expenditure by governments and private sectors coupled with growing investments by multinational companies for expanding their business operations within this region. In addition, increasing demand for generic drugs due to cheaper pricing structure is another factor driving regional growth. Furthermore, government initiatives encouraging research activities pertaining 3D perfusion bioreactor systems are expected propel market expansion over next eight years or so (Kumar & Srivastava 2015).
Growth Factors:
- Increasing demand for organ transplantation: The increasing demand for organ transplantation is one of the key growth drivers for the 3D perfusion bioreactor system market. According to the Organ Procurement and Transplantation Network (OPTN), as of May 2017, there were more than 114,000 people in the U.S. waiting for an organ transplant. This number is only expected to grow in the coming years due to rising incidence of chronic diseases such as diabetes and heart disease. The need for organs has led to a rise in initiatives such as donation campaigns and increase in number of live donor transplants across regions worldwide. This is likely to drive the demand for 3D perfusion bioreactors over the forecast period, thereby propelling market growth
- Technological advancements: The technological advancements taking place across various industries are also fuelling market growth globally. In particular, there has been a surge in R&D activities aimed at developing novel technologies that can improve tissue engineering outcomes using 3D perfusion bioreactors systems These technological advancements are helping researchers achieve better control over cell-environment interactions within three-dimensional scaffolds, which is resulting in improved tissue regeneration outcomes Thus, with continuous innovations taking place within this technology segment; it is likely that 3D perfusion bioreactor systems will witness high adoption rates overthe forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
3D Perfusion Bioreactor System Market Research Report
By Type
Components, Device
By Application
Biopharmaceutical Companies, Biotechnology, Others
By Companies
SYNTHECON, Sigma-Aldrich, 3D Biotek, TA Instruments, Biogenuix, CELLEC BIOTEK AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global 3D Perfusion Bioreactor System Market Report Segments:
The global 3D Perfusion Bioreactor System market is segmented on the basis of:
Types
Components, Device
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Biotechnology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SYNTHECON
- Sigma-Aldrich
- 3D Biotek
- TA Instruments
- Biogenuix
- CELLEC BIOTEK AG
Highlights of The 3D Perfusion Bioreactor System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Components
- Device
- By Application:
- Biopharmaceutical Companies
- Biotechnology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 3D Perfusion Bioreactor System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A 3D perfusion bioreactor system is a type of bioreactor that uses three dimensions to improve the efficiency and effectiveness of the process. This type of system allows for more accurate control over the flow and distribution of nutrients, which can lead to increased production rates.
Some of the key players operating in the 3d perfusion bioreactor system market are SYNTHECON, Sigma-Aldrich, 3D Biotek, TA Instruments, Biogenuix, CELLEC BIOTEK AG.
The 3d perfusion bioreactor system market is expected to grow at a compound annual growth rate of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 3D Perfusion Bioreactor System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 3D Perfusion Bioreactor System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 3D Perfusion Bioreactor System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 3D Perfusion Bioreactor System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 3D Perfusion Bioreactor System Market Size & Forecast, 2020-2028
4.5.1 3D Perfusion Bioreactor System Market Size and Y-o-Y Growth
4.5.2 3D Perfusion Bioreactor System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Components
5.2.2 Device
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Biotechnology
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 3D Perfusion Bioreactor System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 3D Perfusion Bioreactor System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Components
9.6.2 Device
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Biotechnology
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Components
10.6.2 Device
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Biotechnology
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Components
11.6.2 Device
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Biotechnology
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Components
12.6.2 Device
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Biotechnology
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Components
13.6.2 Device
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Biotechnology
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 3D Perfusion Bioreactor System Market: Competitive Dashboard
14.2 Global 3D Perfusion Bioreactor System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SYNTHECON
14.3.2 Sigma-Aldrich
14.3.3 3D Biotek
14.3.4 TA Instruments
14.3.5 Biogenuix
14.3.6 CELLEC BIOTEK AG
